Portfolio Co Investors 2026 for Symbiosis: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Symbiosis accounts for 3 tracked companies with verified cap-table data, 3 of which disclose round sizes totalling $578M. The median disclosed raise is $135M, and the largest is FogPharma at $323M, ahead of SalioGen Therapeutics ($135M) and Carisma Therapeutics ($120M).
The names that recur most often on these co-invested cap tables are Symbiosis (3 companies), Fidelity Management & Research Company (2 companies), ARCH Venture Partners (1 company), Milky Way Investments (1 company), Nextech Invest (1 company), RA Capital Management (1 company). By latest disclosed round, the market skews Series B (2), Series D (1).